Ask AI
DESTINY-Breast05
DESTINY-Breast05: Interim Analysis of a Phase III Trial of Adjuvant T-DXd vs T-DM1 for High-Risk HER2+ EBC With Residual Invasive Disease After Neoadjuvant Therapy

Released: October 23, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 23, 2025